Bacteria-host interplay in Staphylococcus aureus infections by Kwiecinski, Jakub
                                                          
 
 
Bacteria – host interplay in Staphylococcus 
aureus infections 
                                   
Akademisk avhandling 
 
                Som för avläggande av medicine doktorsexamen vid Göteborgs Universitet  
                                           kommer att offentligen försvaras i förelasningssalen (plan 3),  
Avd. för reumatologi och inflammationsforskning, Guldhedsgatan 10A, Göteborg 
Onsdagen den 12 juni, 2013, kl 09.00 
 
                                                                      av 
 
                                                            Jakub Kwiecinski 
 
               Avhandlingen baseras på följande delarbeten: 
 
I.            Kwiecinski J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T, Jin T, 
Bokarewa M. Activation of plasminogen by staphylokinase reduces the severity of 
Staphylococcus aureus systemic infection. J Infect Dis 2010; 202: 1041-1049. 
 
II.           Kwiecinski J, Jacobsson G, Karlsson M, Zhu X, Wang W, Bremell T, Josefsson E, 
Jin T. Staphylokinase promotes the establishment of Staphylococcus aureus skin 
infections while decreasing disease severity. J Infect Dis 2013, in press. 
 
III.         Kwiecinski J, Jin T, Josefsson E. Surface proteins of Staphylococcus aureus play an 
important role in experimental skin infection in mice. Manuscript. 
 
IV.         Kwiecinski J, Rhost S, Löfbom L, Blomqvist M, Månsson JE, Cardell SL, Jin T.  
Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d  
dependent pathway. Infect Immun 2013; 81: 1114-1120. 
 
                                                
Fakultetsopponent: 
 
Professor Heiko Herwald 
Division of Infection Medicine, Department of Clinical Sciences Lund 
Lund University, Lund 
 
ABSTRACT 
 
              
Bacteria – host interplay in Staphylococcus aureus infections 
Jakub Kwiecinski 
Department of Rheumatology and Inflammation Research 
Institute of Medicine, Sahlgrenska Academy 
 
 
Staphylococcus aureus infections are a major healthcare challenge and new treatment 
alternatives are needed. The key to new therapies is understanding the interplay between 
bacterial virulence factors and host immune response, which decides on disease outcome. S. 
aureus produces numerous virulence factors. Among them are the surface proteins and 
soluble factors, like staphylokinase (Sak) – a protein activating host plasminogen. Recently 
characterized subset of leukocytes, the natural killer T-cells (NKT) respond rapidly to 
bacterial challenge and link innate and adaptive immunity. Activation of NKT cells might 
possibly affect the outcome of S. aureus infections. 
 
In this thesis, I explored the role of certain bacteria components (surface proteins, Sak) and 
host factors (NKT cells, plasminogen) during infectious process. Various mouse infection 
models (S. aureus skin infections, septic arthritis, and sepsis), as well as in vitro models and 
collections of clinical bacterial isolates were used. 
 
Staphylococcal surface proteins were crucial for establishment of abscess-like skin infection 
in mice. Activation of host plasminogen by Sak was an important element for staphylococcal 
invasion into the skin and establishment of new infectious sites. However, once infection was 
established, Sak diminished the infection severity and reduced the damage. Benifical effect of 
plasminogen activated by Sak was also observed in S. aureus systemic infection. On the host 
side, the NKT cells were involved in experimental S. aureus sepsis, but they didn’t appear to 
have a significant impact on the disease outcome. However, sulfatide treatment activating the 
type II NKT cells significantly reduced mortality in experimental S. aureus sepsis. 
 
Staphylococcal infection is a complex process, regulated by various staphylococcal factors 
interacting with host: both by surface proteins and by secreted proteins like Sak. Those 
bacterial factors might be potential future treatment targets for limiting disease severity. 
Another potential treatment strategy is to activate type II NKT cells, which downregulates 
exaggerated immune response in S. aureus sepsis, leading to less tissue damage and better 
survival. 
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